MITORAINBOW THERAPEUTICS, INC.
MitoRainbow Therapeutics
CARY, United States · Founded 2022
- Headquarters
- CARY, North Carolina
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- mitorainbow.com
About
MitoRainbow Therapeutics is developing MTR1, a novel small-molecule treatment for thymidine kinase deficiency (TK2d), a mitochondrial disease causing progressive muscle weakness, breathing difficulties, and early death in children. The drug works by restoring mitochondrial DNA synthesis to overcome mtDNA depletion. The company addresses a broader class of mitochondrial genetic disorders with no current approved therapies.
Summary
MITORAINBOW THERAPEUTICS, INC. is a Biotech company based in CARY, United States, founded in 2022.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/mitorainbow-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/mitorainbow-therapeutics-inc" alt="MITORAINBOW THERAPEUTICS, INC. on Indexed.vc" width="260" height="76" /></a>